0000899243-18-019328.txt : 20180703
0000899243-18-019328.hdr.sgml : 20180703
20180703190237
ACCESSION NUMBER: 0000899243-18-019328
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180701
FILED AS OF DATE: 20180703
DATE AS OF CHANGE: 20180703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Satvat Ali J.
CENTRAL INDEX KEY: 0001621788
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38533
FILM NUMBER: 18939047
MAIL ADDRESS:
STREET 1: C/O KOHLBERG KRAVIS ROBERTS & CO.
STREET 2: 2800 SAND HILL ROAD, SUITE 200
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eidos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001731831
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463733671
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-391-9740
MAIL ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-01
0
0001731831
Eidos Therapeutics, Inc.
EIDX
0001621788
Satvat Ali J.
C/O EIDOS THERAPEUTICS, INC.
101 MONTGOMERY STREET, SUITE 2550
SAN FRANCISCO
CA
94104
1
0
1
0
Stock Option (right to buy)
20.34
2018-07-01
4
A
0
43056
0.00
A
2028-06-30
Common Stock
43056
43056
D
The Reporting Person is a participant in the Issuer's 2018 Stock Option and Incentive Plan and received 43,056 stock options (the "Grant") on July 2, 2018. The Grant shall vest as follows: one-third of the stock options shall vest annually over a period of three (3) years following June 29, 2018 subject to the Reporting Person's continued service to the Issuer through each vesting date.
/s/Franco Valle, as Attorney-in-Fact
2018-07-03